BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Saturday, December 27, 2025
Home » Authors » James Etheridge

Articles by James Etheridge

Cellectis and Genomic Vision Receive €10M for HIV/Herpes

Nov. 5, 2008
By James Etheridge
No Abstract BioWorld International CorrespondentPARIS - Two French biotech firms, Cellectis SA and Genomic Vision SA, have launched a joint project for the development of a revolutionary treatment for HIV and herpes.
Read More

Néovacs Initiates Phase I/II of TNF-alpha Kinoid in Crohn's

Oct. 29, 2008
By James Etheridge

Commission Approves €90M for 'Theranostics' Program

Oct. 29, 2008
By James Etheridge
No Abstract BioWorld International CorrespondentPARIS - The European Commission has given the go-ahead for France's Innovation and Small Business Promotion Agency (OSEO) to provide a grant of €89.5 million (US$112.2 million) for a medical research program being coordinated by Mérieux Alliance.
Read More

Immutep to Carry Out Phase I Trial of ImmuFact IMP321 in U.S.

Oct. 22, 2008
By James Etheridge

Endotis Pharma Obtains R&D of €4.5M from Public Sources

Oct. 15, 2008
By James Etheridge
No Abstract BioWorld International CorrespondentPARIS - Endotis Pharma, which is developing small-glyco drugs for applications in thrombosis and oncology, has obtained public funding of €4.5 million (US6.1 million) from three sources to finance ongoing research programs.
Read More

Two French Companies in IP Battle in U.S. Court

Oct. 15, 2008
By James Etheridge

NicOx Signs Naproxcinod Agreement with Capsugel

Oct. 1, 2008
By James Etheridge

ExonHit Therapeutics to Provide Genomic Services to French CRO

Oct. 1, 2008
By James Etheridge

Cellectis and AFM to Develop Genome Surgery for Diseases

Sep. 24, 2008
By James Etheridge

LibraGen and DSM Team to Produce Chiral Amines

Sep. 24, 2008
By James Etheridge
Previous 1 2 3 4 5 6 7 8 9 … 90 91 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Dec. 24, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Dec. 24, 2025.
  • Illustration of magnifying glass looking at cancer in the brain

    Researchers discover how glioblastoma tumors dodge chemotherapy

    BioWorld MedTech
    Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
  • Left: Anthony Fauci. Right: Transmission electron micrograph of HIV-1 virus particles

    HIV research is close to a cure but far from ending the pandemic

    BioWorld
    Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
  • Illustration of tau accumulating in a neuron cell.

    ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug

    BioWorld
    ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing